Improve public health outcomes in communities served

There is strong evidence that assessment and feedback, along with other elements, such as incentives and exchange, are effective in increasing vaccination rates. The CDC established Immunization Quality Improvement for Providers (IQIP) — the national Vaccines for Children provider-level quality improvement program — to assist and support healthcare personnel by identifying low immunization rates and opportunities for improving immunization delivery practices. IQIP replaced the CDC’s AFIX program on July 1, 2019.

The focus of the program is to support the implementation of immunization quality improvement strategies in provider offices to increase on-time vaccination of children and adolescents. To help meet this goal, the Gainwell Immunization Quality Improvement for Providers module supports workflows that assess healthcare providers’ vaccination coverage levels and immunization practices. This module includes IQIP assessments and has been developed to allow an Immunization Information System (IIS) to perform provider-level assessments.

Gainwell provides the tools for you to assess performance, enabling providers to determine how well they are doing through systematic, routine examination of client records, achieve higher immunization rates and improve their immunization practices.

Immunizations are one of the most effective public health interventions to date, with immunization programs successfully preventing or controlling a large number of infectious diseases across the United States. Today, all 50 states, the District of Columbia and all U.S. territories have at least one regional or local Immunization Information System (IIS) that serves the vital purpose of enabling healthcare authorities to ensure high vaccination coverage across the entire community. The emergence of COVID-19 reinforces the value of each IIS in promoting community health, as an effective IIS is key to immunization ordering and distribution, as well as reporting the vaccine doses administered and the coverage rates to both the state and Centers for Disease Control.

Gainwell’s inSight Analytics for Immunization Service helps your agency get more use out of information. This dynamic analytical reporting solution enables your data analysts and information workers to interact with content-rich dashboards and multiple visualizations to discover metrics about your population. Drilling into the data enables you to track how metrics trend over time so, for example, you can discover unusual trends for earlier intervention and mitigation. These dashboards also allow public health entities to more easily share information.

Through our highly secure cloud and analytics platform, your team can gather information from a variety of data sources. In addition to data from your IIS, inSight Analytics relies on a growing list of external data sources — including census data and disease surveillance system data – that can close information gaps and add deeper insights.

The CDC applies nationally consistent standard definitions and classifications for blood lead surveillance data from all states. The purpose of the Blood Lead Registry is to provide providers with the information necessary to determine whether a child should be tested for blood lead. Without a registry, this information is often not otherwise available or easily accessible.

The Gainwell Blood Lead Registry Service facilitates the efficient sharing of results in order to provide accurate and timely intervention in lead screening programs to track health attributes. The service is built on the Wisconsin Immunization Registry, a State of Wisconsin licensed application available for customization.

Through flexible data collection, rich network analysis and visualization, public health professionals can quickly and efficiently follow up on cases, report on general trends and transmit data. The Registry gives providers the ability to submit test results to the state if the test is done locally or, if providers do not have the ability to test, the state can provide the blood lead testing information in a timely manner.

Gainwell has the experience to not only implement a Blood Lead Registry for you, but also integrate it with your Immunization Information System (IIS). In fact, our solution can also serve as a bridge between your state’s IIS and an external lead registry.

Maintaining a Parkinson’s Disease Registry offers an opportunity to increase knowledge about the prevention and optimal treatment of Parkinson’s disease; increase our understanding of associated causes and risk factors; and ultimately improve the lives of those affected and those at risk.

The Gainwell Parkinson’s Disease Registry Service is a database that can be utilized for Parkinson’s research, for healthcare requirements planning and for educating healthcare providers. The Parkinson’s Registry is built on the Wisconsin Immunization Registry, a State of Wisconsin licensed application available for customization. Our service allows your state to:

• Determine the incidence and prevalence of Parkinson’s disease
• Examine disparities in Parkinson’s disease risk
• Conduct demographic and epidemiological research and other studies of Parkinson’s disease

Hepatitis B infection in a pregnant woman poses a serious risk to her infant at birth. Infants who become infected with hepatitis B virus (HBV) have a 90 percent risk for developing chronic HBV infection and a 25 percent lifetime risk for dying prematurely from cirrhosis or hepatocellular carcinoma.

The Gainwell Perinatal Hep B Service is a repository that increases efficiency in providing accurate and timely intervention to assist in the prevention of transmission of Hep B infection from mothers to their infants. The Hep B service is built on the Wisconsin Immunization Registry, a State of Wisconsin licensed application available for customization. Through flexible data collection, rich network analysis and visualization, public health professionals can quickly and efficiently follow up on cases.

This service supports the strategy to eliminate mother-to-child transmission of HBV by preventing infants born to hepatitis B surface antigen (HBsAg)-positive women from becoming infected. In fact, preventing perinatal HBV transmission is an integral part of the national strategy to eliminate hepatitis B in the United States. National guidelines call for the following:

• Universal screening of pregnant women for HBsAg during each pregnancy
• Case management of HBsAg-positive mothers and their infants
• Provision of immunoprophylaxis for infants born to infected mothers, including hepatitis B vaccine and hepatitis B immune globulin (HBIG)
• Routine vaccination of all infants with the hepatitis B vaccine series, with the first dose administered within 24 hours of birth